Quarterly Results

REMEDIUM LIFECARE LTD.

NSE : NABSE : 539561ISIN CODE : INE549S01036Industry : TradingHouse : Private
BSE111.35-3.15 (-2.75 %)
PREV CLOSE ( ) 114.50
OPEN PRICE ( ) 113.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 470387
TODAY'S LOW / HIGH ( )108.80 113.70
52 WK LOW / HIGH ( ) 42.9179.66
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
Audited
UnAudited
Audited
Net Sales
18341.78
4685.7
3304.65
755.8
Total Expenditure
17794.78
4622.26
3231.82
784.77
PBIDT (Excl OI)
547
63.43
72.82
-28.97
Other Income
141.16
40.76
NA
0.99
Operating Profit
688.16
104.2
72.82
-27.98
Interest
0.26
NA
0.00
NA
Exceptional Items
NA
NA
NA
NA
PBDT
687.9
104.2
72.82
-27.98
Depreciation
0.13
0.15
0.14
0.14
Profit Before Tax
687.77
104.05
72.68
-28.12
Tax
NA
38.78
20.22
19.7
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
687.77
65.26
52.46
-47.82
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
687.77
65.26
52.46
-47.82
Equity Capital
100.8
100.8
36
36
Face Value (IN RS)
5
5
10
10
Reserves
Calculated EPS
34.11
3.23
14.57
-13.28
Calculated EPS (Annualised)
136.46
12.95
58.29
-53.13
No of Public Share Holdings
19936000
19936000
3560000
3560000
% of Public Share Holdings
98.89
98.89
98.89
98.89
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
2.98
1.35
2.20
-3.83
PBIDTM%
3.75
2.22
2.20
-3.70
PBDTM%
3.75
2.22
2.20
-3.70
PBTM%
3.74
2.22
2.19
-3.72
PATM%
3.74
1.39
1.58
-6.32
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.